Literature DB >> 21849536

APP is phosphorylated by TrkA and regulates NGF/TrkA signaling.

Carmela Matrone1, Alessia P M Barbagallo, Luca R La Rosa, Fulvio Florenzano, Maria T Ciotti, Delio Mercanti, Moses V Chao, Pietro Calissano, Luciano D'Adamio.   

Abstract

The pathogenic model of Alzheimer's disease (AD) posits that aggregates of amyloid β, a product of amyloid precursor protein (APP) processing, cause dementia. However, alterations of normal APP functions could contribute to AD pathogenesis, and it is therefore important to understand the role of APP. APP is a member of a gene family that shows functional redundancy as documented by the evidence that single knock-out mice are viable, whereas mice with combined deletions of APP family genes die shortly after birth. A residue in the APP intracellular region, Y(682), is indispensable for these essential functions of APP. It is therefore important to identify pathways that regulate phosphorylation of Y(682) as well as the role of Y(682) in vivo. TrkA is associated with both phosphorylation of APP-Y(682) and alteration of APP processing, suggesting that tyrosine phosphorylation of APP links APP processing and neurotrophic signaling to intracellular pathways associated with cellular differentiation and survival. Here we have tested whether the NGF/TrkA signaling pathway is a physiological regulator of APP phosphorylation. We find that NGF induces tyrosine phosphorylation of APP, and that APP interacts with TrkA and this interaction requires Y(682). Unpredictably, we also uncover that APP, and specifically Y(682), regulates activation of the NGF/TrkA signaling pathway in vivo, the subcellular distribution of TrkA and the sensitivity of neurons to the trophic action of NGF. This evidence suggests that these two membrane protein's functions are strictly interconnected and that the NGF/TrkA signaling pathway is involved in AD pathogenesis and can be used as a therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21849536      PMCID: PMC3319322          DOI: 10.1523/JNEUROSCI.1960-11.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  22 in total

1.  A short cytoplasmic domain of the amyloid precursor protein induces apoptosis in vitro and in vivo.

Authors:  E Bertrand; E Brouillet; I Caillé; C Bouillot; G M Cole; A Prochiantz; B Allinquant
Journal:  Mol Cell Neurosci       Date:  2001-11       Impact factor: 4.314

2.  A single tyrosine residue in the amyloid precursor protein intracellular domain is essential for developmental function.

Authors:  Alessia P M Barbagallo; Zilai Wang; Hui Zheng; Luciano D'Adamio
Journal:  J Biol Chem       Date:  2011-01-25       Impact factor: 5.157

3.  Tyrosine phosphorylation of the beta-amyloid precursor protein cytoplasmic tail promotes interaction with Shc.

Authors:  Philip E Tarr; Roberta Roncarati; Giuliana Pelicci; Pier Giuseppe Pelicci; Luciano D'Adamio
Journal:  J Biol Chem       Date:  2002-03-04       Impact factor: 5.157

4.  Genetic dissection of the amyloid precursor protein in developmental function and amyloid pathogenesis.

Authors:  Hongmei Li; Zilai Wang; Baiping Wang; Qinxi Guo; Georgia Dolios; Katsuhiko Tabuchi; Robert E Hammer; Thomas C Südhof; Rong Wang; Hui Zheng
Journal:  J Biol Chem       Date:  2010-08-06       Impact factor: 5.157

Review 5.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

6.  Phosphorylation of a tyrosine in the amyloid-beta protein precursor intracellular domain inhibits Fe65 binding and signaling.

Authors:  Dawang Zhou; Nicola Zambrano; Tommaso Russo; Luciano D'Adamio
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

7.  Generation of an apoptotic intracellular peptide by gamma-secretase cleavage of Alzheimer's amyloid beta protein precursor.

Authors:  B Passer; L Pellegrini; C Russo; R M Siegel; M J Lenardo; G Schettini; M Bachmann; M Tabaton; L D'Adamio
Journal:  J Alzheimers Dis       Date:  2000-11       Impact factor: 4.472

8.  The interactome of the amyloid beta precursor protein family members is shaped by phosphorylation of their intracellular domains.

Authors:  Robert Tamayev; Dawang Zhou; Luciano D'Adamio
Journal:  Mol Neurodegener       Date:  2009-07-14       Impact factor: 14.195

9.  Growth factor receptor-bound protein 2 interaction with the tyrosine-phosphorylated tail of amyloid beta precursor protein is mediated by its Src homology 2 domain.

Authors:  Dawang Zhou; Cristiana Noviello; Chiara D'Ambrosio; Andrea Scaloni; Luciano D'Adamio
Journal:  J Biol Chem       Date:  2004-03-30       Impact factor: 5.157

10.  Evidence that the Amyloid beta Precursor Protein-intracellular domain lowers the stress threshold of neurons and has a "regulated" transcriptional role.

Authors:  Luca Giliberto; Dawang Zhou; Richard Weldon; Elena Tamagno; Pasquale De Luca; Massimo Tabaton; Luciano D'Adamio
Journal:  Mol Neurodegener       Date:  2008-09-02       Impact factor: 14.195

View more
  32 in total

1.  Tyr682 in the Aβ-precursor protein intracellular domain regulates synaptic connectivity, cholinergic function, and cognitive performance.

Authors:  Carmela Matrone; Siro Luvisetto; Luca R La Rosa; Robert Tamayev; Annabella Pignataro; Nadia Canu; Li Yang; Alessia P M Barbagallo; Fabrizio Biundo; Franco Lombino; Hui Zheng; Martine Ammassari-Teule; Luciano D'Adamio
Journal:  Aging Cell       Date:  2012-10-12       Impact factor: 9.304

2.  The amyloid precursor protein modulates α2A-adrenergic receptor endocytosis and signaling through disrupting arrestin 3 recruitment.

Authors:  Fang Zhang; Mary Gannon; Yunjia Chen; Lufang Zhou; Kai Jiao; Qin Wang
Journal:  FASEB J       Date:  2017-06-23       Impact factor: 5.191

3.  Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration.

Authors:  Wei Xu; April M Weissmiller; Joseph A White; Fang Fang; Xinyi Wang; Yiwen Wu; Matthew L Pearn; Xiaobei Zhao; Mariko Sawa; Shengdi Chen; Shermali Gunawardena; Jianqing Ding; William C Mobley; Chengbiao Wu
Journal:  J Clin Invest       Date:  2016-04-11       Impact factor: 14.808

4.  Withdrawal of BDNF from hippocampal cultures leads to changes in genes involved in synaptic function.

Authors:  Abigail Mariga; Jiri Zavadil; Stephen D Ginsberg; Moses V Chao
Journal:  Dev Neurobiol       Date:  2014-08-25       Impact factor: 3.964

5.  Paradoxical effect of TrkA inhibition in Alzheimer's disease models.

Authors:  Qiang Zhang; Olivier Descamps; Matthew J Hart; Karen S Poksay; Patricia Spilman; Darci J Kane; Olivia Gorostiza; Varghese John; Dale E Bredesen
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 6.  Nerve growth factor and Alzheimer's disease: new facts for an old hypothesis.

Authors:  Antonino Cattaneo; Pietro Calissano
Journal:  Mol Neurobiol       Date:  2012-09-01       Impact factor: 5.590

Review 7.  APP Receptor? To Be or Not To Be.

Authors:  Carole Deyts; Gopal Thinakaran; Angèle T Parent
Journal:  Trends Pharmacol Sci       Date:  2016-01-31       Impact factor: 14.819

8.  TrkB receptor cleavage by delta-secretase abolishes its phosphorylation of APP, aggravating Alzheimer's disease pathologies.

Authors:  Yiyuan Xia; Zhi-Hao Wang; Pai Liu; Laura Edgington-Mitchell; Xia Liu; Xiao-Chuan Wang; Keqiang Ye
Journal:  Mol Psychiatry       Date:  2020-08-11       Impact factor: 15.992

9.  Low molecular weight, non-peptidic agonists of TrkA receptor with NGF-mimetic activity.

Authors:  D Scarpi; D Cirelli; C Matrone; G Castronovo; P Rosini; E G Occhiato; F Romano; L Bartali; A M Clemente; G Bottegoni; A Cavalli; G De Chiara; P Bonini; P Calissano; A T Palamara; E Garaci; M G Torcia; A Guarna; F Cozzolino
Journal:  Cell Death Dis       Date:  2012-07-05       Impact factor: 8.469

10.  Tau-Driven Neuronal and Neurotrophic Dysfunction in a Mouse Model of Early Tauopathy.

Authors:  Nadia Mazzaro; Erica Barini; Maria Grazia Spillantini; Michel Goedert; Paolo Medini; Laura Gasparini
Journal:  J Neurosci       Date:  2016-02-17       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.